New real-world data shows Abbott’s FreeStyle Libre Technology delivers significant health benefits for people with Type 2 diabetes
Abbott has announced new data from a real-world evidence study in Sweden showing that the use of the FreeStyle Libre continuous glucose monitoring system (CGM)